InvestorsHub Logo
Post# of 251673
Next 10
Followers 827
Posts 119535
Boards Moderated 15
Alias Born 09/05/2002

Re: caravon post# 219532

Monday, 06/03/2019 11:32:50 AM

Monday, June 03, 2019 11:32:50 AM

Post# of 251673
VICL reverse-merges into (private) Brickell Biotech:

https://www.globenewswire.com/news-release/2019/06/03/1862969/0/en/Vical-and-Brickell-Announce-Merger-Agreement.html

Brickell’s lead pipeline asset, sofpironium bromide, is a pivotal Phase 3-ready topical soft anticholinergic intended for axillary hyperhidrosis.

… existing Vical stockholders will own 40% of the combined company and Brickell stockholders will own 60% of the combined company…

…Following the Merger, the combined company will be led by the current Brickell management team… The board of directors of the combined company will be comprised of seven directors, including five current directors of Brickell…

VICL investors don’t like the deal, evidently; the stock is -13% as I’m typing.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.